Navigation Links
A Recent Study by ITG's Majestic Market Research Indicates a Strong Launch for Gilenya in Spite of Its Time-Consuming Initiation Process
Date:6/1/2011

ation process.  Neurologists described an overwhelming degree of red tape affiliated with the reimbursement of Ampyra.  Of surveyed Ampyra prescribers, 40% reported reimbursement issues with the drug.  Unlike Gilenya, Ampyra's launch appears to be greatly hindered by these issues.  Since neurologists view Ampyra's efficacy as questionable and limited to a niche subset of the MS population, they seem less willing to jump through hoops to get patients on it.  The difference in how neurologists are handling Gilenya versus Ampyra is indicative of the cost-benefit analysis that is inherent in every treatment decision.  Neurologists have made more of a commitment to Gilenya because they believe it can deliver meaningful benefits to their patients and Novartis is facilitating the delivery of those benefits.  This hasn't been the case with Ampyra.  Data from ITG's proprietary physician panel have pointed to waning demand for Ampyra, which the study concludes is unlikely to improve without material changes to the drug's reimbursement situation.

Conducted in April - May 2011, the study includes analysis of a targeted Internet survey of 100 neurologists and proprietary longitudinal treatment data from a panel of 225 neurologists spanning 2005-2011. Through triangulation of quantitative and qualitative findings from these two data sources, the report provides an in-depth look at the launch of Gilenya and the potential for future oral disease-modifying drugs in the multiple sclerosis market. In addition, the report evaluates uptake and use of Acorda Therapeutics' Ampyra as a supportive agent in the MS space.

About Event Pulse


SOURCE ITG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
4. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
5. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
6. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
7. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
8. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
11. Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... of Fair Trading (OFT) approval condition to the announced tender offer ...   As a result of the waiver, the transaction ... complete the tender offer on January 24, 2014 following the currently ...
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to announce the ... new Chief Executive Officer.  Mark was promoted from his current ... the company,s four facilities in Massachusetts , ... joined Tegra Medical in 2012 with 20+ years of broad-based ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... Calif., April 24, 2012  A dose of 10 milligrams (mg) ... fermented soy germ-based nutritional supplement is as effective as a ... significantly and is even more effective for relieving muscle and ... women published in the June Journal of Women,s Health ...
... April 24, 2012  The Intellectual Property & Science ... to support R&D pharmaceutical leaders with a new ... use by AstraZeneca executives. The rich visualization dashboard ... , the company,s flagship life sciences platform, ...
Cached Medicine Technology:Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 2Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 3Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 4Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 5Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 6Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 7Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women 8Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders 2
(Date:4/16/2014)... 16, 2014): Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced ... of CDX-1401 in solid tumors, including long-term patient follow-up, ... (Vol 6 Issue 232). The data demonstrate robust antibody ... in patients with very advanced cancers and suggest that ...
(Date:4/16/2014)... , DOWNERS GROVE, Ill. April 16, 2014 ... of surveillance colonoscopy in average-risk patients with one to ... about 90 percent of cases. This may be an ... multicenter endoscopic database study to quantify adherence to guidelines ...
(Date:4/15/2014)... in the United States have nearly doubled since 1988, suggests ... Health, with obesity apparently to blame for the surge. The ... not hit all groups equally, with alarming increases in diabetes ... research reported in the April 15, 2014 issue of the ...
(Date:4/15/2014)... a decades-old medical mystery and in the process have found ... kill about 1.5 million people a year. The researchers say they ... that has been in use for more than 50 years ... it is to the microbes it attacks. , A report ...
(Date:4/15/2014)... California, San Diego School of Medicine have identified a mechanism ... liver disease and why the virus is able to persist ... pathogen, which infects an estimated 200 million people worldwide, attacks ... the cell,s innate ability to fight infection. It does this ...
Breaking Medicine News(10 mins):Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Breaking bad mitochondria 2
... China Healthcare Acquisition Corp. (the "Company") (NYSE Alternext ... meeting held today, March 5, 2009, its stockholders voted ... early distribution of the Company,s trust fund for the ... March 5, 2009. Today,s vote had the automatic effect ...
... FRANKLIN, Tenn., March 5 /PRNewswire/ -- ... services, today announced details for the release of its financial ... plans to issue its earnings release for the fourth quarter ... March 25, 2009, and will host a conference call on ...
... not getting services they need to prevent another attack, ... After suffering a stroke, the chances of having another ... aren,t getting the interventions they need to reduce that ... smoking cessation and exercise, and medical treatments, such as ...
... the Aspen Health Stewardship Project will unveil a new ... support of a roadmap for making smart, sustainable improvements ... which includes patient groups, and health employer and provider ... America by adopting a set of core principles to ...
... Re-enrollment OpportunitiesHARRISBURG, Pa., March 5 Insurance ... laid off from a job that offered health insurance ... provide them with relief on premiums and that now ... information."I want to let Pennsylvanians know that additional help ...
... it has received a $76 million grant from the Bill ... and young child nutrition in developing countries in Africa and ... to increase rates of exclusive breastfeeding and improve complementary feeding ... children die and millions more are permanently disabled as a ...
Cached Medicine News:Health News:China Healthcare Acquisition Corp. Announces Stockholder Approval of Charter Amendment to Permit Early Distribution of Its Trust Fund and to Permit Its Continued Existence Without Blank Check Company Provisions and Sets Payment Date 2Health News:Second Stroke Prevention Efforts Found Wanting 2Health News:Second Stroke Prevention Efforts Found Wanting 3Health News:Aspen Institute to Introduce Roadmap for Responsible Health Care Reform, New Coalition To Call For Sustainable Improvements 2Health News:Pennsylvanians Encouraged to Take Another Look at COBRA Options 2Health News:AED Receives Gates Foundation Grant to Improve Nutrition and Reduce Deaths Among Young Children in Developing Countries 2
...
...
... biomechanical properties influence the results and ... and may hold clues to diagnosing ... assessing the biomechanical properties of corneal ... practitioners and researchers to measuring purely ...
The Surgiflex WAVE is a comfortable, easy to use, versatile, and interchangeable suction-irrigation device....
Medicine Products: